Charcot Foot

2

Review clinical trials related to Charcot Foot. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors

Diabetes mellitus (DM) is among the most common metabolic disorders globally. According to the data from international research, the number of persons with diabetes mellitus reached 366 million in 2011 and is predicted to increase to 552 million by 2030.

Participants needed: 60
Trial details
Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Aug 24, 2025
Eligibility criteria

Adult Patients who are diagnosed with DM who are willing to participate in the s...

Patients with neuritis / neuropathy of the lower extremity due to other causes o... [+6]

Status: Recruiting

The DENOCHARCOT Trial

The aim of the present trial is to assess the efficacy of treatment of acute Charcot foot in diabetes patients with Prolia® on clinical relevant Outcomes in a randomized, double blind, placebo-controlled trial.

Participants needed: 38
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Ole Lander SvendsenUpdated: Aug 7, 2024Locations: 8
Eligibility criteria

Age 18-80 years [+3]

Duration of the acute Charcot foot for more than 3 months (at the screening visi... [+23]